SODA-LO® Salt Microspheres Patent Granted in USA
09 May 2013 11:00
SODA-LO® Salt Microspheres Patent Granted in USA
Patent covers both the salt reduction product and the manufacturing process
Tate Lyle, a global provider of ingredients and solutions to the food and beverage industries, announces that on 7 May 2013 a patent was granted in the US covering the SODA-LO® Salt Microspheres commercial product and the process to make it.
SODA-LO® is a ground breaking, new salt reduction ingredient that tastes, labels and functions like salt because it is salt. With SODA-LO®, food manufacturers can reduce salt levels by 25 to 50 percent in various applications without sacrificing taste.
The newly patented technology turns standard salt crystals into free-flowing crystalline microspheres. These smaller, lower-density crystals efficiently deliver salty taste by maximizing surface area relative to volume. SODA-LO® Salt Microspheres makes it possible to enjoy clean salt taste while consuming lower levels of sodium. Because SODA-LO® is made from real salt, it has none of the bitter aftertaste or off-flavours associated with some other salt compounds or substitutes.
"The granting of the patent confirms the novelty of SODA-LO® and establishes it as a truly innovative salt reduction ingredient” said Angelique Gunderson, Health and Wellness Platform Commercial Lead at Tate Lyle.
The industry has also recognised SODA-LO® Salt Microspheres with a number of innovation awards. In September of 2012, SODA-LO® Salt Microspheres was recognised as one of the most innovative new ingredients at Food Ingredients South America. In November 2012, SODA-LO® was recognised as the "Heart Health and Circulatory Innovation of the Year" and as the overall "Most Innovative Health Ingredient of the Year" from the 2012 Nutrition Wellness Excellence Awards, which recognise individuals and business for their exemplary work and contribution to the industry.
The patent relating to SODA-LO® Salt Microspheres is owned by Eminate Limited, a wholly owned subsidiary of The University of Nottingham, UK. Tate Lyle licensed SODA-LO® on an exclusive basis from Eminate in October 2011. Under the license agreement, Tate Lyle assumes responsibility for commercialising the SODA-LO® salt reduction technology on a global basis including manufacturing, product development, sales and marketing.
“We are delighted to be partnering with Tate Lyle on SODA-LO® and the granting of this patent serves to strengthen the ingredient’s novelty and future potential”, said Neil Davidson, Chairman of Eminate Limited.
SODA-LO® Salt Microspheres is patented in the USA and New Zealand. It remains patent pending in other locations including Europe.
Tate Lyle has developed a number of applications incorporating SODA-LO® resulting in salt reductions of 25 to 50 percent including various breads and doughs, topicals such as peanuts, potato chips and French Fries, breadings and seasoning blends. Work continues to assess its suitability in a number of other applications.
Notes to Editors:
About Tate Lyle: Tate Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, operating from over 30 production facilities around the world.
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC.
About Eminate Limited: Eminate Ltd is a wholly owned subsidiary of The University of Nottingham, founded in 2006, with expertise in the design and commercial application of micro and nano particles, coatings and powders. Eminate Ltd was established with help from a grant from the government-backed Technology Strategy Board (www.innovateuk.org), which works to create economic growth by ensuring that the UK is a global leader in innovation.
The business operates across a range of sectors including food ingredients, health, pharmaceuticals, and energy storage.
Novel, patented, products have already been developed within the company, and taken to first commercial sale / license, in the food ingredients, functional foods and engineering coatings markets. Eminate’s research and development teams continue to work in close partnership with a range of companies, universities and research organisations to develop new products and provide innovative solutions to commercial challenges.
Eminate is based in the East Midlands with offices, research laboratory, and production facilities in Sutton Bonington and Nottingham.
For more information contact:
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
